Home › Compare › ZINGW vs MRK

ZINGW vs MRK: Dividend Comparison 2026

ZINGW yields 200000.00% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ZINGW wins by $4.911780474428384e+29M in total portfolio value
10 years
ZINGW
ZINGW
● Live price
200000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.911780474428384e+29M
Annual income
$490,695,411,370,591,700,000,000,000,000,000,000.00
Full ZINGW calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — ZINGW vs MRK

📍 ZINGW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZINGWMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZINGW + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ZINGW pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZINGW
Annual income on $10K today (after 15% tax)
$17,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$417,091,099,665,002,940,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, ZINGW beats the other by $417,091,099,665,002,940,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZINGW + MRK for your $10,000?

ZINGW: 50%MRK: 50%
100% MRK50/50100% ZINGW
Portfolio after 10yr
$2.455890237214192e+29M
Annual income
$245,347,705,685,295,860,000,000,000,000,000,000.00/yr
Blended yield
99.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ZINGW
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZINGW buys
0
MRK buys
0
No recent congressional trades found for ZINGW or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZINGWMRK
Forward yield200000.00% ✓3.25%
Annual dividend / share$2.00$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR0%8.2% ✓
Portfolio after 10y$4.911780474428384e+29M$30.7K ✓
Annual income after 10y$490,695,411,370,591,700,000,000,000,000,000,000.00 ✓$950.29
Total dividends collected$4.911464459982279e+29M$6.1K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ZINGW vs MRK ($10,000, DRIP)

YearZINGW PortfolioZINGW Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$20,010,700$20,000,000.00$11,192$351.54+$20.00M → ZINGW
2$37,424,589,019$37,403,177,570.09$12,524$392.70+$37424.58M → ZINGW
3$65,416,215,188,220$65,376,170,877,969.18$14,015$438.65+$65416215.17M → ZINGW
4$106,868,230,495,008,900$106,798,235,144,757,520.00$15,682$489.96+$106868230494.99M → ZINGW
5$163,172,871,735,896,870,000$163,058,522,729,267,200,000.00$17,547$547.23+$163172871735896.84M → ZINGW
6$232,854,599,801,468,860,000,000$232,680,004,828,711,460,000,000.00$19,632$611.16+$232854599801468864.00M → ZINGW
7$310,570,858,137,017,100,000,000,000$310,321,703,715,229,540,000,000,000.00$21,963$682.53+$310570858137017057280.00M → ZINGW
8$387,148,154,301,613,200,000,000,000,000$386,815,843,483,406,600,000,000,000,000.00$24,571$762.18+$3.871481543016132e+23M → ZINGW
9$451,061,749,763,281,040,000,000,000,000,000$450,647,501,238,178,360,000,000,000,000,000.00$27,486$851.08+$4.510617497632811e+26M → ZINGW
10$491,178,047,442,838,440,000,000,000,000,000,000$490,695,411,370,591,700,000,000,000,000,000,000.00$30,745$950.29+$4.911780474428384e+29M → ZINGW

ZINGW vs MRK: Complete Analysis 2026

ZINGW — Stock

FTAC Zeus Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to identify technology and financial services technology companies. The company was formerly known as FTAC Hera Acquisition Corp. and changed its name to FTAC Zeus Acquisition Corp. in February 2021. FTAC Zeus Acquisition Corp. was incorporated in 2020 and is based in Philadelphia, Pennsylvania.

Full ZINGW Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this ZINGW vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZINGW vs SCHDZINGW vs JEPIZINGW vs OZINGW vs KOZINGW vs MAINZINGW vs JNJZINGW vs ABBVZINGW vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.